The global market for Psoriatic Arthritis Therapeutics was valued at US$ 7585 million in the year 2024 and is projected to reach a revised size of US$ 13720 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Psoriatic Arthritis Therapeutics Market

Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Therapeutics.

The Psoriatic Arthritis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriatic Arthritis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Psoriatic Arthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Psoriatic Arthritis Therapeutics Market Report

Report Metric	Details
Report Name	Psoriatic Arthritis Therapeutics Market
Accounted market size in year	US$ 7585 million
Forecasted market size in 2031	US$ 13720 million
CAGR	9.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Nonsteroidal Anti-Inflammatory Drug Disease-Modifying Antirheumatic Drug Biologic Drug Enzyme Inhibitor
Segment by Application	Hospitals Clinics Research Labs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Bayer, Novartis, Abbott Laboratories, Sanofi, Bristol-Myers Squibb, Janssen Biotech, Amgen, UCB, AbbVie
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Psoriatic Arthritis Therapeutics Market growing?

Ans: The Psoriatic Arthritis Therapeutics Market witnessing a CAGR of 9.0% during the forecast period 2025-2031.

What is the Psoriatic Arthritis Therapeutics Market size in 2031?

Ans: The Psoriatic Arthritis Therapeutics Market size in 2031 will be US$ 13720 million.

Who are the main players in the Psoriatic Arthritis Therapeutics Market report?

Ans: The main players in the Psoriatic Arthritis Therapeutics Market are Pfizer, Bayer, Novartis, Abbott Laboratories, Sanofi, Bristol-Myers Squibb, Janssen Biotech, Amgen, UCB, AbbVie

What are the Application segmentation covered in the Psoriatic Arthritis Therapeutics Market report?

Ans: The Applications covered in the Psoriatic Arthritis Therapeutics Market report are Hospitals, Clinics, Research Labs

What are the Type segmentation covered in the Psoriatic Arthritis Therapeutics Market report?

Ans: The Types covered in the Psoriatic Arthritis Therapeutics Market report are Nonsteroidal Anti-Inflammatory Drug, Disease-Modifying Antirheumatic Drug, Biologic Drug, Enzyme Inhibitor

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Nonsteroidal Anti-Inflammatory Drug

1.2.3 Disease-Modifying Antirheumatic Drug

1.2.4 Biologic Drug

1.2.5 Enzyme Inhibitor

1.3 Market by Application

1.3.1 Global Psoriatic Arthritis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Labs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Psoriatic Arthritis Therapeutics Market Perspective (2020-2031)

2.2 Global Psoriatic Arthritis Therapeutics Growth Trends by Region

2.2.1 Global Psoriatic Arthritis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Psoriatic Arthritis Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Psoriatic Arthritis Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Psoriatic Arthritis Therapeutics Market Dynamics

2.3.1 Psoriatic Arthritis Therapeutics Industry Trends

2.3.2 Psoriatic Arthritis Therapeutics Market Drivers

2.3.3 Psoriatic Arthritis Therapeutics Market Challenges

2.3.4 Psoriatic Arthritis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue

3.1.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Psoriatic Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Psoriatic Arthritis Therapeutics Revenue

3.4 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio

3.4.1 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Revenue in 2024

3.5 Global Key Players of Psoriatic Arthritis Therapeutics Head office and Area Served

3.6 Global Key Players of Psoriatic Arthritis Therapeutics, Product and Application

3.7 Global Key Players of Psoriatic Arthritis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Psoriatic Arthritis Therapeutics Breakdown Data by Type

4.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2026-2031)

5 Psoriatic Arthritis Therapeutics Breakdown Data by Application

5.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Psoriatic Arthritis Therapeutics Market Size (2020-2031)

6.2 North America Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Psoriatic Arthritis Therapeutics Market Size by Country (2020-2025)

6.4 North America Psoriatic Arthritis Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Psoriatic Arthritis Therapeutics Market Size (2020-2031)

7.2 Europe Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Psoriatic Arthritis Therapeutics Market Size by Country (2020-2025)

7.4 Europe Psoriatic Arthritis Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Psoriatic Arthritis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Psoriatic Arthritis Therapeutics Market Size (2020-2031)

9.2 Latin America Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Psoriatic Arthritis Therapeutics Introduction

11.1.4 Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Psoriatic Arthritis Therapeutics Introduction

11.2.4 Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.2.5 Bayer Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Psoriatic Arthritis Therapeutics Introduction

11.3.4 Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Abbott Laboratories

11.4.1 Abbott Laboratories Company Details

11.4.2 Abbott Laboratories Business Overview

11.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Introduction

11.4.4 Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.4.5 Abbott Laboratories Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Psoriatic Arthritis Therapeutics Introduction

11.5.4 Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.5.5 Sanofi Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Introduction

11.6.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Janssen Biotech

11.7.1 Janssen Biotech Company Details

11.7.2 Janssen Biotech Business Overview

11.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Introduction

11.7.4 Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.7.5 Janssen Biotech Recent Development

11.8 Amgen

11.8.1 Amgen Company Details

11.8.2 Amgen Business Overview

11.8.3 Amgen Psoriatic Arthritis Therapeutics Introduction

11.8.4 Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.8.5 Amgen Recent Development

11.9 UCB

11.9.1 UCB Company Details

11.9.2 UCB Business Overview

11.9.3 UCB Psoriatic Arthritis Therapeutics Introduction

11.9.4 UCB Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.9.5 UCB Recent Development

11.10 AbbVie

11.10.1 AbbVie Company Details

11.10.2 AbbVie Business Overview

11.10.3 AbbVie Psoriatic Arthritis Therapeutics Introduction

11.10.4 AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025)

11.10.5 AbbVie Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Nonsteroidal Anti-Inflammatory Drug

Table 3. Key Players of Disease-Modifying Antirheumatic Drug

Table 4. Key Players of Biologic Drug

Table 5. Key Players of Enzyme Inhibitor

Table 6. Global Psoriatic Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Psoriatic Arthritis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Psoriatic Arthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Psoriatic Arthritis Therapeutics Market Share by Region (2020-2025)

Table 10. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Psoriatic Arthritis Therapeutics Market Share by Region (2026-2031)

Table 12. Psoriatic Arthritis Therapeutics Market Trends

Table 13. Psoriatic Arthritis Therapeutics Market Drivers

Table 14. Psoriatic Arthritis Therapeutics Market Challenges

Table 15. Psoriatic Arthritis Therapeutics Market Restraints

Table 16. Global Psoriatic Arthritis Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Psoriatic Arthritis Therapeutics Market Share by Players (2020-2025)

Table 18. Global Top Psoriatic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Therapeutics as of 2024)

Table 19. Ranking of Global Top Psoriatic Arthritis Therapeutics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Psoriatic Arthritis Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Psoriatic Arthritis Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Psoriatic Arthritis Therapeutics, Product and Application

Table 23. Global Key Players of Psoriatic Arthritis Therapeutics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Psoriatic Arthritis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type (2020-2025)

Table 27. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type (2026-2031)

Table 29. Global Psoriatic Arthritis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Application (2020-2025)

Table 31. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Application (2026-2031)

Table 33. North America Psoriatic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Psoriatic Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Psoriatic Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Psoriatic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Psoriatic Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Psoriatic Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Psoriatic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Pfizer Company Details

Table 49. Pfizer Business Overview

Table 50. Pfizer Psoriatic Arthritis Therapeutics Product

Table 51. Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 52. Pfizer Recent Development

Table 53. Bayer Company Details

Table 54. Bayer Business Overview

Table 55. Bayer Psoriatic Arthritis Therapeutics Product

Table 56. Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 57. Bayer Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis Psoriatic Arthritis Therapeutics Product

Table 61. Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. Abbott Laboratories Company Details

Table 64. Abbott Laboratories Business Overview

Table 65. Abbott Laboratories Psoriatic Arthritis Therapeutics Product

Table 66. Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 67. Abbott Laboratories Recent Development

Table 68. Sanofi Company Details

Table 69. Sanofi Business Overview

Table 70. Sanofi Psoriatic Arthritis Therapeutics Product

Table 71. Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 72. Sanofi Recent Development

Table 73. Bristol-Myers Squibb Company Details

Table 74. Bristol-Myers Squibb Business Overview

Table 75. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product

Table 76. Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 77. Bristol-Myers Squibb Recent Development

Table 78. Janssen Biotech Company Details

Table 79. Janssen Biotech Business Overview

Table 80. Janssen Biotech Psoriatic Arthritis Therapeutics Product

Table 81. Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 82. Janssen Biotech Recent Development

Table 83. Amgen Company Details

Table 84. Amgen Business Overview

Table 85. Amgen Psoriatic Arthritis Therapeutics Product

Table 86. Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 87. Amgen Recent Development

Table 88. UCB Company Details

Table 89. UCB Business Overview

Table 90. UCB Psoriatic Arthritis Therapeutics Product

Table 91. UCB Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 92. UCB Recent Development

Table 93. AbbVie Company Details

Table 94. AbbVie Business Overview

Table 95. AbbVie Psoriatic Arthritis Therapeutics Product

Table 96. AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 97. AbbVie Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Psoriatic Arthritis Therapeutics Picture

Figure 2. Global Psoriatic Arthritis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Psoriatic Arthritis Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Nonsteroidal Anti-Inflammatory Drug Features

Figure 5. Disease-Modifying Antirheumatic Drug Features

Figure 6. Biologic Drug Features

Figure 7. Enzyme Inhibitor Features

Figure 8. Global Psoriatic Arthritis Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Psoriatic Arthritis Therapeutics Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. Research Labs Case Studies

Figure 13. Psoriatic Arthritis Therapeutics Report Years Considered

Figure 14. Global Psoriatic Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Psoriatic Arthritis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Psoriatic Arthritis Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Psoriatic Arthritis Therapeutics Market Share by Players in 2024

Figure 18. Global Top Psoriatic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Therapeutics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Therapeutics Revenue in 2024

Figure 20. North America Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Psoriatic Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Psoriatic Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Psoriatic Arthritis Therapeutics Market Share by Region (2020-2031)

Figure 34. China Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Psoriatic Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Psoriatic Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Psoriatic Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Pfizer Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 50. Bayer Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 52. Abbott Laboratories Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 55. Janssen Biotech Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 56. Amgen Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 57. UCB Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 58. AbbVie Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Viscosupplementation for Knee Osteoarthritis Market

Knee Osteoarthritis Treatment Market

Osteoarthritis Pain Market

Osteoarthritis Drugs Market

Osteoarthritis Medications Market

Hip Replacement Market

Rheumatology Therapeutics Market

Total Hip Replacement Market

Psoriatic Arthritis Therapeutics Market

Digital Therapeutics Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions